3rd Kinase Targeted Drug Discovery Summit

The 3rd Kinase Targeted Drug Discovery Summit is the go-to event for advancing kinase biology and therapeutic innovation. Held in Boston, this summit gathers leading scientists, researchers, and executives from the pharmaceutical, biotechnology, and academic sectors. The agenda focuses on cutting-edge topics like PROTACs, molecular glues, and allosteric inhibitors, while addressing challenges such as drug selectivity, resistance, and combination therapies. The summit aims to push boundaries in small molecule and kinase-targeted treatments, with real-world applications that transform patient outcomes. Unique highlights include presentations from world-class speakers representing institutions like the Dana-Farber Cancer Institute, Novartis, and Biogen. Attendees can explore the latest breakthroughs, network with global thought leaders, and collaborate on strategies to develop best-in-class kinase-targeted drugs. The event provides a focused platform for exploring novel therapeutic approaches and creating meaningful solutions in the fight against complex diseases.